Knight Therapeutics Inc T.GUD

Stifel GMP Presentation

[longrun86]

Hi folks,

I wanted to provide a few of the highlights that I took from the Stifel GMP interview:

• Samira's is getting much more comfortable being in the spotlight and was precise and direct in her responses. Very professional and very confident.

• They are starting to fire on all cyclinders and the operational digestion of Biotoscana is coming to an end.

• She expects Knight's Latam growth rate to be at around the forecast rate for Latam more generally which is in the mid-teens. 

• There are a lot of opportunities for them in the market which makes the possibility of utilizing the shelf listing fairly realisitic.

Overall I felt pretty good about the presentation and where this continues to trend.

Best of luck,

LR

[MrMugsy]

Agreed. Samira was quite excitied about the potential for certain drugs she highlighted in that talk. A large part of the efficiency gain is in place with the remainder to come in 2022 - I believe a large part of the remaining is in manufacturing (Argentina) if I heard correctly. Everything is mostly in place.  That's one thing this team can do ... build and execute a drug licensing

[Chianchin]

Buy back and PP. So, about 7 years ago GUD did a private huge placement at $10. Investors bought on the expectation of fast growth, good investemnts nand profits. Thus a return of 8% on the $10 PP the today share price would have to be atleast at $15. Move forward to today GUD is buying back at $5 those share sold to stiffed investors for $10. Would any of those investors  who bought the PP

[Chianchin]

Each LATAM economic growth needs to be  re-balanced against their inflation rate. Example Argentina inflation is 52% If argentina growth rate is 15%, the actual growth is 52 - 15 = minus 43%. Good luck making GUD 

[Chianchin]

Correction Argentina growth rate Minus 37%

[Candyswanwick]

You realize that PP was done because share price got way ahead of itself from a bs repurchase of Endo rumour, right? It's exactly what I would want management to do. Venturing into LATAM is not something I wanted though. 

[Chianchin]

I agre Candy, they were fast, smart and opportunistic  with the PP at $10. Later they were too slow and failled in the lost cause of  adventurism in LATAM while they ignored many opportunities in developped markets. Thus MNGT and BDO are only delaying the inevitable to resighn 

[MrMugsy]

Agreed Candyswanwick ... the Paladin buyback rumour was certainly part of it.  I don't doubt there was a discussion but I'm also sure Goodman wasn't going to pay the price the original Endo CEO wanted. I'm sure Goodman was just testing the waters. Also, if memory serves me correctly, we went to market twice before that $10 PP.  We also received $140M CAD for the sale of

[porksniffer]

  Yeah and now there is a shelf prospectus and the market will not let them raise anything more than $5/share or possible less depending on the discount. Management is buying shares above this price burning up shareholder cash because after 7 years are essentially useless trying to improve fundamentals.. Yet they have this shelf they are desperatly tying to execute. Market is not stupid and